Bovine Anaplasmosis (Anaplasma marginale)

Bovine anaplasmosis is a tick-borne infectious disease of cattle caused by the obligate intraerythrocytic rickettsial organism Anaplasma marginale. The disease is characterized by progressive anemia, fever, icterus, and weight loss, with severe economic losses in both dairy and beef production systems. The pathogen invades mature erythrocytes, leading to extravascular hemolysis primarily in the spleen and liver. The clinical severity ranges from subclinical infection in endemic areas to peracute death in naïve adult cattle. The disease is of major global importance, particularly in tropical and subtropical regions, but also occurs in temperate zones where competent tick vectors exist. In dairy cattle, anaplasmosis can cause significant drops in milk production, increased culling rates, and reproductive failures. In beef cattle, it leads to reduced weight gain, abortion, and mortality, especially in adult animals. The disease is often referred to as 'gall sickness' in some regions due to the icteric appearance of affected animals. The economic impact includes direct losses from mortality, treatment costs, and indirect losses from decreased productivity and trade restrictions.

The primary causative agent is Anaplasma marginale, a gram-negative, obligate intracellular bacterium belonging to the family Anaplasmataceae, order Rickettsiales. The organism infects mature erythrocytes, where it forms inclusion bodies (initial bodies) that are visible on stained blood smears as dense, basophilic, marginal bodies. A. marginale is distinguished from the less pathogenic A. centrale by the location of the inclusion bodies within the erythrocyte (marginal vs. central). The organism has a complex life cycle involving both vertebrate and invertebrate hosts. In cattle, the organism undergoes cyclic development within erythrocytes, with a generation time of approximately 24 hours. The bacterium possesses surface proteins (MSP1a, MSP1b, MSP2, MSP3, MSP4, MSP5) that are involved in adhesion to erythrocytes and immune evasion. The organism is transmitted biologically by ticks, mechanically by blood-contaminated fomites (needles, dehorning saws, ear tagging pliers), and transplacentally from dam to fetus. The major tick vectors include Rhipicephalus (Boophilus) microplus, Rhipicephalus annulatus, Dermacentor andersoni, Dermacentor variabilis, and Ixodes ricinus. The organism can also be transmitted by biting flies such as tabanids and stable flies. The infectious dose is low, with as little as 1 microliter of blood containing the organism capable of transmitting infection. The organism is not shed in milk, urine, or feces, and direct contact transmission does not occur.

Bovine anaplasmosis is endemic in many tropical, subtropical, and some temperate regions of the world, including parts of Africa, Asia, Australia, Central and South America, and the southern United States. The prevalence is influenced by the distribution of competent tick vectors, cattle management practices, and the presence of carrier animals. In endemic areas, cattle become infected at a young age (usually under 2 years) and develop a persistent carrier state with low-level rickettsemia, which confers lifelong immunity. Clinical disease is most common in adult cattle (over 2 years) that are introduced into endemic areas or in endemic herds where management practices (e.g., vaccination, chemoprophylaxis) are not implemented. Morbidity can be high, with up to 60% of susceptible adult cattle becoming clinically affected during outbreaks. Mortality rates range from 20% to 50% in untreated adult cattle, but can be higher in peracute cases. In dairy herds, anaplasmosis can cause significant economic losses due to decreased milk production (up to 50% reduction in affected cows), increased culling, and reproductive disorders such as abortion and reduced conception rates. In beef cattle, weight loss and mortality are the primary economic impacts. The disease is more prevalent in the summer and fall months when tick activity is highest. Herd-level risk factors include lack of biosecurity, introduction of new animals, and sharing of contaminated equipment. Individual animal risk factors include age (older animals are more susceptible), breed (Bos taurus breeds are more susceptible than Bos indicus), and immune status.

The pathophysiology of bovine anaplasmosis involves a complex interplay between the pathogen, the host immune response, and the erythrocyte. After transmission, A. marginale initially replicates in the host's reticuloendothelial system, particularly in the spleen, liver, and lymph nodes, before invading erythrocytes. The organism enters erythrocytes by endocytosis and multiplies by binary fission, forming inclusion bodies. The infected erythrocytes are then removed from circulation by the mononuclear phagocyte system, primarily in the spleen, leading to extravascular hemolysis. The severity of anemia is directly proportional to the level of rickettsemia, which can reach up to 70% of erythrocytes infected. The destruction of erythrocytes leads to a regenerative anemia characterized by polychromasia, anisocytosis, and reticulocytosis. The release of hemoglobin is metabolized to bilirubin, leading to icterus without significant hemoglobinuria (because the liver can conjugate the bilirubin). The anemia results in tissue hypoxia, which can cause weakness, depression, and in severe cases, cardiovascular collapse. The immune response involves both humoral and cell-mediated mechanisms. Antibodies against surface proteins (MSPs) are produced, but the organism undergoes antigenic variation of MSP2, allowing it to evade the immune response and establish a persistent infection. The spleen plays a crucial role in the clearance of infected erythrocytes, and splenectomized animals are more susceptible to severe disease. The disease can also cause immunosuppression, increasing susceptibility to secondary infections. In pregnant cows, the stress of infection can lead to abortion, likely due to fever and hypoxia.

Several intrinsic and extrinsic factors predispose cattle to bovine anaplasmosis. Intrinsic factors include age, breed, and immune status. Adult cattle (over 2 years) are more susceptible to severe clinical disease than younger animals, which often develop mild or subclinical infections. Bos taurus breeds are more susceptible than Bos indicus breeds, which have a natural resistance to tick infestation and possibly to the pathogen. Immunosuppressed animals, such as those with concurrent diseases or under stress, are more likely to develop severe disease. Extrinsic factors include management practices that increase the risk of mechanical transmission, such as the use of contaminated needles, dehorning saws, ear tagging pliers, and other blood-contaminated instruments. The presence of competent tick vectors is a major risk factor, and the disease is more common in areas with high tick populations. Seasonal variation in tick activity influences the incidence of disease, with peaks in late summer and fall. The introduction of new animals into a herd without proper quarantine and testing can introduce the pathogen. Lack of biosecurity measures, such as not testing new animals for carrier status, increases the risk of outbreaks. In dairy herds, the use of pooled colostrum or blood-contaminated milk replacer can also transmit the disease. Additionally, stress factors such as transportation, parturition, and poor nutrition can exacerbate the clinical severity of the disease.

The clinical signs of bovine anaplasmosis vary depending on the age and immune status of the animal, as well as the stage of infection. The incubation period is typically 3 to 8 weeks after transmission. In peracute cases, animals may die suddenly without premonitory signs, especially in adult cattle. In acute cases, the first signs are fever (up to 41°C), depression, anorexia, and a drop in milk production. As the disease progresses, signs of anemia become evident, including pale mucous membranes, weakness, and exercise intolerance. Icterus (jaundice) develops as the anemia worsens, with yellowing of the mucous membranes, sclera, and skin. The feces may become dry and constipated, and the urine may be dark yellow due to bilirubinuria, but hemoglobinuria is not a feature. Respiratory rate and heart rate are increased due to the anemia. In severe cases, animals may become recumbent and develop a downer cow syndrome. Pregnant cows may abort, especially in the last trimester. In endemic areas, young animals (under 2 years) often show only mild fever and transient anemia, and they develop immunity. In adult animals, the disease is more severe, and without treatment, mortality can be high. In the recovery phase, animals gradually regain appetite and strength, but milk production may not return to pre-infection levels for several weeks. Some animals become carriers and remain persistently infected, serving as a source of infection for other animals.

The differential diagnoses for bovine anaplasmosis include other causes of hemolytic anemia, fever, and icterus in cattle. Key differentials include: 1) Babesiosis (Babesia bovis, B. bigemina): caused by intraerythrocytic protozoa, transmitted by ticks, and characterized by fever, anemia, hemoglobinuria, and sometimes neurological signs. Blood smears show intraerythrocytic piroplasms, and the disease is more acute with hemoglobinuria. 2) Bacillary hemoglobinuria (Clostridium haemolyticum): caused by a clostridial toxin that causes hemolysis and liver necrosis, often associated with liver fluke infestation. It presents with sudden death, hemoglobinuria, and necrotic liver lesions. 3) Leptospirosis (Leptospira interrogans serovars): causes hemolytic anemia, fever, and icterus, but also often causes hemoglobinuria and renal failure. Diagnosis is by serology or PCR. 4) Theileriosis (Theileria spp.): transmitted by ticks, causes fever, anemia, and lymphadenopathy, but is more common in certain regions. Blood smears show piroplasms in erythrocytes and schizonts in lymphocytes. 5) Eperythrozoonosis (Mycoplasma wenyonii): causes mild anemia and fever, but is less severe. 6) Acute lead poisoning: can cause anemia and neurological signs, but not typically icterus. 7) Postparturient hemoglobinuria: occurs in recently calved cows due to phosphorus deficiency, causing hemolysis and hemoglobinuria. 8) Copper toxicity: can cause hemolytic crisis and icterus, but is rare. 9) Onion or brassica toxicity: can cause Heinz body anemia and hemolysis. 10) Autoimmune hemolytic anemia: rare in cattle. Definitive diagnosis is based on blood smears, serology, PCR, and response to treatment.

The diagnostic algorithm for bovine anaplasmosis begins with a thorough herd history and physical examination. Key historical findings include recent introduction of new animals, tick exposure, and previous cases in the herd. Physical examination findings of fever, pale mucous membranes, icterus, and anemia should raise suspicion. The next step is to collect blood samples for hematology and blood smears. A complete blood count (CBC) will show anemia (decreased packed cell volume, hemoglobin, and red blood cell count) and reticulocytosis. A blood smear stained with Giemsa or Wright's stain should be examined for the presence of A. marginale inclusion bodies at the margins of erythrocytes. In acute cases, the organisms are easily seen, but in carrier animals, they may be rare, and more sensitive tests are needed. Serological tests such as competitive ELISA (cELISA) for antibodies against MSP5 are used for herd screening and to detect carriers. PCR-based assays (e.g., real-time PCR targeting the msp1β gene) are highly sensitive and specific for detecting A. marginale DNA in blood. In cases where the diagnosis is unclear, a splenectomy of a suspect animal can be used to amplify the organism, but this is rarely done. Other diagnostic tests include the complement fixation test (CFT), which is less sensitive than ELISA. It is important to rule out other causes of hemolytic anemia, so additional tests may include blood smears for Babesia, serology for Leptospira, and biochemical tests for liver function. The diagnostic algorithm should also include a necropsy of any dead animals, which may show pale tissues, icterus, and an enlarged, dark spleen.

Laboratory findings in bovine anaplasmosis are characteristic and include: 1) Hematology: A normocytic, normochromic to macrocytic, regenerative anemia is present. Packed cell volume (PCV) may drop from normal (24-36%) to below 15% in severe cases. Hemoglobin concentration and red blood cell count are decreased. Reticulocytosis is present, with increased polychromasia and anisocytosis on blood smears. Nucleated red blood cells may be seen. White blood cell count is usually within normal limits or slightly decreased. Platelet count is typically normal. 2) Blood smear: The presence of A. marginale inclusion bodies at the margins of erythrocytes is diagnostic. The inclusion bodies are dense, basophilic, and round to oval, measuring 0.3-1.0 μm in diameter. They are often multiple within a single erythrocyte. 3) Serum biochemistry: Total bilirubin is elevated, predominantly unconjugated (indirect) bilirubin, due to hemolysis. Liver enzymes such as aspartate aminotransferase (AST) and gamma-glutamyl transferase (GGT) may be mildly elevated due to hepatic hypoxia. Blood urea nitrogen (BUN) and creatinine may be elevated if there is renal impairment. 4) Urinalysis: Bilirubinuria is present, but hemoglobinuria is absent. 5) Serology: Competitive ELISA (cELISA) detects antibodies against MSP5, which appear within 2-3 weeks after infection and persist for years. A positive cELISA indicates exposure, but not necessarily active infection. 6) PCR: Real-time PCR detects A. marginale DNA in blood, which is highly sensitive and specific. It can detect carriers with low-level rickettsemia. 7) Other: In chronic cases, serum iron and ferritin may be decreased due to iron sequestration. The direct Coombs test may be positive in some cases due to antibody-coated erythrocytes.

Imaging modalities are not commonly used for the diagnosis of bovine anaplasmosis, but they can be helpful in assessing the severity of anemia and ruling out other conditions. Ultrasonography of the spleen and liver may show splenomegaly and hepatomegaly, but these findings are nonspecific. Thoracic ultrasonography may reveal pleural effusion or pulmonary edema in severe cases due to heart failure. Abdominal ultrasonography may show ascites in cases of right-sided heart failure. Radiography is not useful for the diagnosis of anaplasmosis. In research settings, advanced imaging such as magnetic resonance imaging (MRI) or computed tomography (CT) may be used to study the effects of anemia on organs, but these are not practical in the field. The primary diagnostic tools remain blood smears, serology, and PCR.

Cytology and histopathology are not routinely used for the diagnosis of bovine anaplasmosis, but they can be performed on necropsy tissues. On histopathology, the spleen shows marked erythrophagocytosis, hemosiderin deposition, and lymphoid hyperplasia. The liver shows centrilobular necrosis due to hypoxia, with accumulation of hemosiderin in Kupffer cells. The bone marrow shows erythroid hyperplasia in response to the anemia. In the lungs, there may be edema and congestion. In the kidneys, there may be tubular necrosis due to hypoxia. On cytology of bone marrow aspirates, there is an increase in erythroid precursors. In blood smears, the inclusion bodies are the key cytological finding. Immunohistochemistry can be used to detect A. marginale antigens in tissues, but this is rarely needed. In chronic carriers, the spleen may contain organisms in macrophages, but they are not visible on routine histology.

The treatment of bovine anaplasmosis involves antimicrobial therapy, supportive care, and management of anemia. The primary antimicrobials used are tetracyclines, particularly oxytetracycline and chlortetracycline. Oxytetracycline is administered intravenously or subcutaneously at a dose of 10-20 mg/kg body weight, repeated every 24 hours for 3-5 days. Long-acting oxytetracycline (20 mg/kg) can be given as a single subcutaneous injection. Chlortetracycline can be administered orally in feed at a dose of 1-2 mg/lb body weight per day for 30-60 days to eliminate the carrier state. Imidocarb dipropionate is also effective, but it is not approved in all countries; it is given subcutaneously at a dose of 3-5 mg/kg, repeated after 24 hours. Supportive care includes blood transfusions in severely anemic animals (PCV < 12%) to improve oxygen-carrying capacity. Whole blood or packed red blood cells can be transfused at a rate of 10-20 ml/kg over 4-6 hours. Fluid therapy with isotonic crystalloids is indicated to maintain hydration and support blood pressure. Anti-inflammatory drugs such as flunixin meglumine (1.1-2.2 mg/kg IV) can be used to reduce fever and inflammation. In severe cases, dexamethasone (0.05-0.1 mg/kg IV) may be used to reduce inflammation, but it should be used cautiously as it may immunosuppress. Nutritional support with high-quality feed and supplements is important. In endemic areas, vaccination with live A. centrale or killed A. marginale vaccines can be used as a preventive measure, but these are not available in all countries. It is important to implement biosecurity measures to prevent further transmission, such as using clean needles and equipment, and controlling ticks.

The prognosis for bovine anaplasmosis depends on the age, immune status, and severity of infection. In young animals (under 2 years), the prognosis is generally good, as they often develop mild disease and recover without treatment. In adult cattle, the prognosis is guarded, especially if treatment is delayed. With prompt antimicrobial therapy and supportive care, the mortality rate can be reduced from 30-50% to less than 5%. However, severely anemic animals (PCV < 10%) have a poor prognosis, and death may occur despite treatment. Animals that recover may have a prolonged recovery period, with milk production returning to normal over several weeks. Some animals become carriers and remain persistently infected, which can lead to chronic ill-thrift and reduced productivity. The long-term prognosis for carriers is generally good, but they serve as a source of infection for other animals. In pregnant cows, abortion may occur, which can affect future reproductive performance. The economic impact of the disease can be significant, with losses from mortality, treatment costs, and decreased production.

Follow-up care for animals recovering from bovine anaplasmosis includes monitoring for recurrence of clinical signs and ensuring complete recovery. Animals should be monitored for 2-4 weeks after treatment, with regular assessment of PCV, body condition, and milk production. In dairy cows, milk production should be monitored to ensure it returns to expected levels. If the animal is a carrier, it should be identified and either isolated or treated to eliminate the carrier state. Herd-level follow-up includes implementing biosecurity measures to prevent introduction of the disease, such as testing new animals for carrier status and quarantining them. Tick control measures should be implemented, including the use of acaricides and pasture management. In endemic areas, vaccination programs may be considered. Regular herd testing with cELISA or PCR can help identify carriers and monitor the disease status. It is also important to review and improve management practices to reduce the risk of mechanical transmission, such as using disposable needles and sterilizing surgical instruments.

Clinical pearls: 1) In endemic areas, assume that any adult cow with fever, anemia, and icterus has anaplasmosis until proven otherwise. 2) Blood smears are most likely to be positive during the acute phase (fever), so take samples early. 3) The absence of hemoglobinuria helps differentiate anaplasmosis from babesiosis. 4) Oxytetracycline is the drug of choice; long-acting formulations are convenient for treatment. 5) Blood transfusions can be life-saving in severely anemic animals; use a compatible donor or a bull. 6) Control ticks and mechanical transmission to prevent outbreaks. Pitfalls: 1) Do not wait for laboratory confirmation before starting treatment in a suspected case; treatment is most effective when started early. 2) Do not use corticosteroids as the sole treatment; they do not kill the organism. 3) Do not use imidocarb in lactating dairy cows if it is not approved; check withdrawal times. 4) Do not forget to check for other diseases that may be present concurrently, such as babesiosis or leptospirosis. 5) Do not ignore the carrier state; carriers can spread the disease. 6) Do not use the same needle for multiple animals; this can spread the disease.

Current drug protocols for bovine anaplasmosis are based on Plumb's Veterinary Drug Handbook and AABP guidelines. The primary antimicrobial is oxytetracycline. For acute cases, oxytetracycline hydrochloride is administered intravenously at a dose of 10-20 mg/kg body weight, once daily for 3-5 days. Long-acting oxytetracycline (200 mg/ml) can be given subcutaneously at a dose of 20 mg/kg as a single injection. For elimination of the carrier state, chlortetracycline can be fed at a dose of 1-2 mg/lb body weight per day for 30-60 days. Imidocarb dipropionate is an alternative, given subcutaneously at a dose of 3-5 mg/kg, repeated after 24 hours; it is not approved in all countries and has a long withdrawal time. Supportive care includes intravenous fluids: isotonic crystalloids (e.g., lactated Ringer's solution) at a rate of 20-40 ml/kg/hour for the first hour, then maintenance rates. Hypertonic saline (7.2% NaCl) at 4-5 ml/kg IV over 10-15 minutes can be used for rapid volume expansion, followed by isotonic fluids. Blood transfusions: whole blood at 10-20 ml/kg IV over 4-6 hours. Anti-inflammatory drugs: flunixin meglumine at 1.1-2.2 mg/kg IV once daily for up to 3 days. Dexamethasone at 0.05-0.1 mg/kg IV once daily for 1-2 days, but use with caution. Withdrawal times: Oxytetracycline has a milk withdrawal of 72 hours and a meat withdrawal of 28 days (depending on formulation). Imidocarb has a meat withdrawal of 90 days and is not approved for lactating dairy cows. Always consult the label and local regulations.

Evidence-based literature on bovine anaplasmosis includes landmark studies on the epidemiology, pathogenesis, and control of the disease. Key findings include: 1) The efficacy of oxytetracycline in treating acute anaplasmosis has been demonstrated in multiple clinical trials, with significant reductions in mortality and morbidity. 2) Long-acting oxytetracycline is as effective as short-acting formulations when used at appropriate doses. 3) Chlortetracycline in feed is effective in eliminating the carrier state, but requires prolonged administration. 4) Imidocarb dipropionate is effective but has safety concerns and is not approved in all countries. 5) Vaccination with live A. centrale provides cross-protection against A. marginale and is used in some countries, but it can cause disease in adult cattle. 6) The use of cELISA for detection of antibodies is highly sensitive and specific for herd screening. 7) PCR is the most sensitive method for detecting carriers. 8) Tick control is essential for preventing the disease, and integrated pest management strategies are recommended. 9) The economic impact of anaplasmosis is significant, with losses estimated at millions of dollars annually in the United States alone. 10) Recent research has focused on the molecular mechanisms of antigenic variation and the development of recombinant vaccines. Consensus guidelines from the AABP and other organizations recommend a comprehensive approach to control, including biosecurity, vector control, and vaccination where appropriate.